A randomized, placebo‐controlled trial evaluating effects of lebrikizumab on airway eosinophilic inflammation and remodelling in uncontrolled asthma (CLAVIER)
Overview of attention for article published in Clinical & Experimental Allergy, October 2020
Altmetric Attention Score: 12
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (83rd percentile)
-
High Attention Score compared to outputs of the same age and source (80th percentile)
Readers on
- mendeley
- 66 Mendeley